0001209191-12-039158.txt : 20120726 0001209191-12-039158.hdr.sgml : 20120726 20120726164636 ACCESSION NUMBER: 0001209191-12-039158 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120725 FILED AS OF DATE: 20120726 DATE AS OF CHANGE: 20120726 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUELLER PETER CENTRAL INDEX KEY: 0001256126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 12987913 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2012-07-25 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001256126 MUELLER PETER C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 0 1 0 0 EVP, Global R&D, CSO Employee Stock Option (right to buy) 48.74 2012-07-25 4 A 0 36250 0.00 A 2022-07-24 Common Stock 36250 36250 D The option vests in 16 quarterly installments beginning on 10/25/2012. Valerie L. Andrews, Attorney-In-Fact 2012-07-26